Get started
Live feed
·
INSIDERFilingvia Quantisnow
Applied DNA Sciences Inc. logo

Applied DNA Sciences (APDN) director Catell received 22,511 shares

ByQuantisnow·Wall Street's wire, on your screen.
Stocks in this Quantisnow insight

Insider transactions reported

Robert B Catell (director at Applied DNA Sciences Inc., APDN) reported that they received 22,511 shares on Oct 17, 2025. After these transactions the filing shows 22,512 shares held directly.

Reporting person
Catell Robert B
Common stock and other non-derivative transactions
DateTypeSecuritySharesPriceValueHeld after
Oct 17, 2025Grant or award (A)Common Stock1+22,511--22,512 direct

Holdings before and after

  • Common Stock: 1 to 22,512 direct

Footnotes from the filing

  1. 1. 100% of the restricted stock units vest upon 90 days from the date of grant

Transaction codes in this filing

Grant or award:
Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.

FAQ

What did Catell report in this APDN Form 4?

Robert B Catell (director at Applied DNA Sciences Inc., APDN) reported that they received 22,511 shares on Oct 17, 2025. After these transactions the filing shows 22,512 shares held directly.

How many APDN shares does Catell hold after this filing?

The filing shows 22,512 shares held directly after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.

What does transaction code A mean on an SEC Form 4?

Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.

Historical context for APDN

Earlier insider filings at APDN

Quantisnow market dataNASDAQ
Applied DNA Sciences Inc. logo
APDN
Applied DNA Sciences Inc.
Market cap
30-day
Sector
Consumer Discretionary
Industry
Other Consumer Services
Get push alerts for APDN

Follow APDN and get a push notification the moment its next story breaks.

Full APDN profile on Quantisnow
Original source Picked up and delivered by Quantisnow in real time

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track APDN (Applied DNA Sciences Inc.) and more on Quantisnow.